Anna Everette
CRISPR represents potential for huge change. But will the public trust it?
The charged language around the recent gene-editing controversy is driving an inaccurate assessment of risks ...
A view from CRISPRcon: Hope, promise and ‘an unmistakable sense of urgency’
The title of this article is partially borrowed from a fascinating Lightning Presentation delivered by John Doench of Broad Institute ...
